The United States has lost its measles-elimination status for the first time since 2000, joining Mexico and Bolivia as sustained transmission of the highly contagious virus reverses years of progress against the disease in the Americas. The decision follows evidence that measles has circulated continuously for at least 12 months in each country, despite established vaccination programmes and efforts to contain outbreaks.
The Pan American Health Organization (PAHO) confirmed the decision on 17 November, following an assessment by its independent regional verification commission. The panel reviewed epidemiological and laboratory evidence from 47 countries and territories during its annual meeting from 10 to 13 November before recommending that the three countries lose their elimination designation.
The findings trace the resurgence to separate outbreaks that began in early 2025. In the United States, continuous transmission dates to 20 January 2025, followed by Mexico on 1 February and Bolivia on 16 April. Each outbreak subsequently crossed the 12-month threshold used to determine whether measles has become endemic again.
Measles elimination does not mean a country has recorded zero infections. Imported cases and limited outbreaks can occur without affecting that designation, provided transmission is interrupted before a year has elapsed. The latest review establishes that the virus continued circulating within all three countries long enough for endemic transmission to be re-established.
The consequences are already visible in regional surveillance figures. According to PAHO's latest epidemiological assessment, the Americas recorded 58,213 measles cases in 2026 through early November. Guatemala accounted for 34,860 infections, followed by Mexico with 13,796 and the United States with 5,182.
The resurgence follows a prolonged erosion of population immunity. Regional vaccination coverage in 2025 remained below the 95% threshold recommended for preventing sustained measles transmission, leaving clusters of susceptible people even in countries with established immunisation systems. These gaps allow imported infections to develop into outbreaks that can continue across successive communities.
Measles spreads through infectious particles in the air and can cause pneumonia, inflammation of the brain and, in severe cases, death. Infants too young to receive routine vaccination and people who cannot be vaccinated for medical reasons face particular risks when community immunity declines.
The decision also deepens an earlier regional setback. The Americas became the first WHO region to eliminate measles in 2016 and regained that status in 2024 after interrupting transmission in Brazil and Venezuela. However, Canada lost its national elimination status in 2025, prompting the withdrawal of the region's collective verification later that year.
Canada has since interrupted the transmission chain responsible for its loss of status and is working towards re-verification. The United States, Mexico and Bolivia are now strengthening vaccination, disease surveillance and outbreak responses, according to PAHO.
Restoring elimination will require evidence that sustained transmission has stopped, rather than simply a decline in reported cases. PAHO is urging countries to maintain at least 95% two-dose vaccine coverage in every community and respond rapidly to suspected infections. The Americas has previously recovered its measles-free designation, but that achievement now depends on interrupting the remaining transmission chains across the region.